The pharmaceutical composition is suitable for magnetic drug targeting.
该药 物组合物适用于磁性药物靶向。
Finally, the present invention also provides a pharmaceutical composition.
最后，本发明还提供了药物组合物。
The second component of the pharmaceutical composition is an antidepressant.
该药物组合物的第二组分为抗抑郁剂。
The first component of the pharmaceutical composition is a sedative eszopiclone.
所述药物组合物的第一种组分是镇静剂艾司佐匹克隆。
New heterocyclic compounds, preparing method, pharmaceutical composition and use.
杂环化合物，制备方法，药物组合物和用途。
Gastrodine derivative, its preparation method, pharmaceutical composition and USES.
天麻素衍生物，其制备方法，药物组合物及其用途。
The pharmaceutical composition is useful in the treatment of pain and inflammation.
本发明的药物组合物可用于治疗疼痛和炎症。
The invention provides a method of treating cancer by administering the pharmaceutical composition.
本发 明提供了通过给予药物组合物来治疗癌症的方法。
The pharmaceutical composition of the invention has excellent effects for treating cardiovascular diseases.
本发明药物组合物用于治疗心血管疾病具有很好的功效。
The invention also concerns a method for preparing said complex and a pharmaceutical composition comprising same.
本发 明亦涉及制备所述络合物和包含其的药物组合物的方法。
S-omeprazole strontium or hydrate thereof, method for preparing same, and pharmaceutical composition comprising same.
奥美拉唑锶或其水合物，它们的制备方法，和包含它们的药物组合物。
The pharmaceutical composition comprises levocarnitine or a derivative thereof and a drug for improving hemodynamics.
该药物组合物包括左卡尼汀或其衍生物和一种改善血流动力学药物。
The pharmaceutical composition can be prepared into tablet, dispersible tablet, oral disintegrating tablet or capsule.
该药物组合物以片剂、分散片、口腔崩解片及胶囊的形式存在。
A pharmaceutical composition and method for use in inhibiting growth of cancer cells in a mammalian subject are disclosed.
本发明公开了用于抑制哺乳动物患者癌细胞生长的药物组合物和方法。
Pharmaceutical composition comprising I. A. vitamin c, magnesium, green tea extract for retarding cardiovascular diseases.
包括I.A。维生素c，镁，绿茶提取物的延缓心血管疾病的药物组合物。
The invention discloses a pharmaceutical composition for treating cardiovascular diseases and a preparation method thereof.
本发明公开了一种治疗心血管疾病的药物组合物及其制备方法。
The invention relates to a pharmaceutical composition, particularly to a pharmaceutical composition with antitumor activity.
本发明涉及一种药物组合物，特别是涉及一种具有抗肿瘤活性的药物组合 物。
Quinazoline derivatives, pharmaceutical composition containing the compound, their utilization and preparation method thereof.
喹唑啉衍生物，含该化合物的药物组合物，其用途及其制备方法。
The invention discloses a pharmaceutical composition with a function of improving the memory and a preparation method thereof.
本发明公开了一种具有改善记忆力功能的药物组合物及其制备方法。
The present invention relates to a pharmaceutical composition with improved dissolution of lipophilic drugs in an aqueous medium.
本发明涉及一种亲脂性药物在水介质中溶出得以改善的药物组合物。
Moreover, the pharmaceutical composition is prepared as soft capsules and has the function of assisting to improve the human memory.
它被制备成软胶囊剂。本发明药物组合物具有辅助改善人体记忆功能的作用。
The invention also relates to a process for preparing the compound of formula (I), and to a pharmaceutical composition comprising it.
本发明还涉及式(i)化合物的制备方法和包含它的药物组合物。
The pharmaceutical composition of the invention has good effects of expelling wind, relieving the exterior, clearing heat and detoxifying.
本发明药物组合物具备很好具有疏风解表，清热解毒作用。
The invention discloses a pharmaceutical composition used for treating virus hepatitis, a preparation method and a quality control method thereof.
本发明公开了一种治疗病毒性肝炎的药物组合物及制备方法和质量控制方法。
In another aspect, the invention provides for a pharmaceutical composition comprising the mentioned polypeptide and medical USES of the polypeptide.
在另一个方面，本发明提供了一种药物组合物，其包括所述多肽及所述多肽的医疗用途。
The invention discloses a pharmaceutical composition with functions of radiation resistance and immunity enhancement and a preparation method thereof.
本发明公开了一种具有抗辐射、增强免疫力功能的药物组合物及其制备方法。
Disclosed is a pharmaceutical composition containing a compound represented by the general formula (I) below, while having improved storage stability.
所公开的是含有右述通式(I)表示的化合物且具有改进的贮存稳定性的药物组合物。
Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections.
抑制膜病毒复制的药物，其生产方法，药物组合物和抑制病毒感染的方法。
The invention discloses a pharmaceutical composition as an iron supplement agent, which comprises ferrous glycinate, antioxidant and medicinal carrying agents.
本发明公开了一种作为补铁剂的药物组合物，其中含有甘氨酸亚铁 和抗氧化剂，并可含有药用载体；
The pharmaceutical composition is prepared with the following raw materials according to a certain weight ratio: lecithin, taurine, flaxseed oil and vitamin e.
该药物组合物是由卵磷脂、牛磺酸、亚麻油、维生素e按一定重量配比制备而成。
应用推荐